205180-02-5

Upstream product

• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 
• 96-41-3 Cyclopentanol 
• 914200-98-9 (S)-2-tert-butoxycarbonylamino-3-phenyl-propionic acid cyclopentyl ester 
• 914200-97-8 (S)-2-amino-3-phenyl-propionic acid cyclopentyl ester tosylate 

Downstream Products

• 957142-87-9 C₁₅H₁₇NO₂S 
• 957142-88-0 C₁₅H₂₀N₂O₂S 
• 914606-08-9 (S)-2-[4-(tert-butoxycarbonylamino-methyl)-benzylamino]-3-phenyl-propionic acid cyclopentyl ester 
• 234768-79-7 2S-{2R-[1-(R,S)-(Benzyloxy-formyl-amino)-ethyl]-4-methyl-pentanoylamino}-3-phenyl-propionic Acid Cyclopentyl Ester 
• 205179-82-4 2S-[2R-(2,2-dimethyl-5-oxo-[1,3]-dioxolan-4S-yl)-4-methyl-pentanoylamino]-3-phenylpropionic acid cyclopentyl ester 
• 234768-73-1 2S-[2-(R,S)-Benzyl-3-(benzyloxy-formyl-amino)-propionylamino]-3-phenyl Propionic Acid Cyclopentyl Ester 

Relevant academic research and scientific papers

THIAZOLE DERIVATIVES AS INHIBITORS OF P13 KINASE

Compounds of formula (I) are inhibitors of P13 kinase activity, and useful in treatment of, inter alia, autoimmune, inflammatory and proliferative diseases: wherein: s is 0 or 1; U is hydrogen or halogen; X is -(C=O), an optionally substituted divalent ph

QUINOLINE DERIVATIVES AS KINASE ENZYME INHIBITORS

Compounds of formula (IA) or (IB) are inhibitors of aurora kinase activity, and are useful in the treatment of cell proliferation disease and other conditions associated with inappropriate aurora kinase activity wherein R1 is a carboxylic acid